Serious adverse events · erectile dysfunction in men with obstructive sleep apnoea
1 finding from 1 review
Sex‐related quality of life (QoL) · erectile dysfunction in men with obstructive sleep apnoea
1 finding from 1 review
Health‐related quality of life · erectile dysfunction in men with obstructive sleep apnoea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events · erectile dysfunction in men with obstructive sleep apnoea
It is very uncertain whether continuous positive airway pressure (CPAP) changes minor adverse events compared with phosphodiesterase type 5 inhibitors (very low certainty).
1 finding from 1 review
Intervention not reported
Length of treatment ‐ nCPAP · infants with bronchiolitis
1 finding from 1 review
Intervention not reported
Primary outcome: improvement in symptoms (respiratory distress/dyspnoea) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: improvement in symptoms (voice quality) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: improvement in quality of life · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: recurrence‐free interval · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in mortality · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in number and/or frequency of surgical interventions and/or time until first relapse requiring surgery · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in number and/or duration of hospital stay(s) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in volume of disease, assessed endoscopically · 23 patients aged two years or older with recurrent respiratory papillomatosis
1 finding from 1 review
FEV1 · adults and children with CF
1 finding from 1 review
Pulmonary exacerbations · adults and children with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Direct measures of mucus clearance · adults and children with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exercise capacity · adults and children with CF
1 finding from 1 review
General well‐being · adults and children with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
LCI · adults and children with CF
1 finding from 1 review
Adverse events · adults and children with CF
1 finding from 1 review
no estimate extracted
20 participants
Low